{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T19:53:33Z","timestamp":1777060413604,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Matern Child Health J"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Hepatitis C virus (HCV) is increasingly prevalent in pregnancy and among people with substance use disorders (SUD). Highly effective treatments are now available for chronic HCV. Qualifying for HCV treatment often requires preauthorization and several clinical criteria, including laboratory assessment of liver function and other infectious diseases and liver imaging to assess for fibrosis. Linkage to care (LTC) models have been shown to assist with obtaining the necessary clinical information (laboratory assessment\/liver imaging) and improving HCV treatment rates in non-pregnant individuals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Description<\/jats:title>\n                <jats:p>Beginning in December 2020, a specialized LTC team identified patients with HCV viremia who were interested in postpartum treatment. The LTC team assisted patients with completing the necessary clinical criteria (laboratory assessment and liver imaging) for HCV treatment. Patients were then linked to infectious disease specialists who prescribed treatment to patients via telemedicine. Most patients identified with HCV were enrolled in our institution\u2019s co-located obstetric and SUD program, which provides continued care until 1\u00a0year postpartum.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Assessment<\/jats:title>\n                <jats:p>In 2019, an internal review identified that none of the 26 pregnant patients with HCV viremia in our co-located obstetric and SUD program were prescribed direct-acting antiviral (DAA) treatment within 12\u00a0months postpartum. Between December 2020 and July 2022, our HCV LTC team identified 34 patients with HCV who were eligible for treatment. Of these patients, 55% (19\/34) obtained all necessary laboratory and liver imaging requirements and 79% (15\/19) were prescribed DAA treatment after a telehealth visit with an infectious disease specialist. All fifteen patients who were prescribed treatment participated in the co-located obstetric and SUD program. The largest barrier to obtaining treatment was completing the necessary laboratory and liver imaging requirements for prescribing DAA. Only one patient who did not receive care in our co-located obstetric and SUD program had completed the necessary laboratory and liver imaging requirements to proceed with treatment but did not follow up with the infectious disease specialist for DAA treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our HCV LTC program was successful in treating postpartum patients for HCV if they participated in the co-located obstetric and SUD program at our institution. Creating a partnership with an infectious disease specialist and utilizing telemedicine were beneficial strategies to connect patients to treatment for HCV during the postpartum period.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10995-023-03770-w","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T15:02:59Z","timestamp":1695913379000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Postpartum Hepatitis C Linkage to Care Program in a Co-located Substance Use Disorders Treatment Model"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5969-4658","authenticated-orcid":false,"given":"Aneesha","family":"Cheedalla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Hinely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Roby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. Trent","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Malvestutto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara M.","family":"Rood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"3770_CR2","unstructured":"2020 Number of Newly Reported Perinatal Hepatitis C | CDC. (2022, September 19). https:\/\/www.cdc.gov\/hepatitis\/statistics\/2020surveillance\/hepatitis-c\/table-3.4.htm"},{"issue":"10","key":"3770_CR3","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/cid\/ciy585","volume":"67","author":"AASLD-IDSA HCV Guidance Panel","year":"2018","unstructured":"AASLD-IDSA HCV Guidance Panel. (2018). Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 67(10), 1477\u20131492. https:\/\/doi.org\/10.1093\/cid\/ciy585","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"2","key":"3770_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1089\/tmj.2022.0065","volume":"29","author":"AM Adams","year":"2023","unstructured":"Adams, A. M., Wu, H., Zhang, F. R., Wajsberg, J. R., & Bruney, T. L. (2023). Postpartum care in the time of COVID-19: The use of telemedicine for postpartum care. Telemedicine Journal and E-Health: THe Official Journal of the American Telemedicine Association, 29(2), 235\u2013241. https:\/\/doi.org\/10.1089\/tmj.2022.0065","journal-title":"Telemedicine Journal and E-Health: THe Official Journal of the American Telemedicine Association"},{"issue":"1","key":"3770_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/cld.912","volume":"16","author":"S Arora","year":"2020","unstructured":"Arora, S., & Thornton, K. (2020). Novel models of hepatitis C virus care delivery: Telemedicine, project ECHO, and integrative care. Clinical Liver Disease, 16(1), 5\u20137. https:\/\/doi.org\/10.1002\/cld.912","journal-title":"Clinical Liver Disease"},{"issue":"3","key":"3770_CR6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/hep.29811","volume":"68","author":"LI Backus","year":"2018","unstructured":"Backus, L. I., Belperio, P. S., Shahoumian, T. A., & Mole, L. A. (2018). Direct-acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease. Hepatology, 68(3), 827\u2013838. https:\/\/doi.org\/10.1002\/hep.29811","journal-title":"Hepatology"},{"issue":"1","key":"3770_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/GRF.0000000000000345","volume":"61","author":"HB Bernstein","year":"2018","unstructured":"Bernstein, H. B., Dunkelberg, J. C., & Leslie, K. K. (2018). Hepatitis C in pregnancy in the era of direct-acting antiviral treatment: Potential benefits of universal screening and antepartum therapy. Clinical Obstetrics and Gynecology, 61(1), 146\u2013156. https:\/\/doi.org\/10.1097\/GRF.0000000000000345","journal-title":"Clinical Obstetrics and Gynecology"},{"issue":"4","key":"3770_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.amjmed.2016.11.019","volume":"130","author":"LA Beste","year":"2017","unstructured":"Beste, L. A., Glorioso, T. J., Ho, P. M., Au, D. H., Kirsh, S. R., Todd-Stenberg, J., Chang, M. F., Dominitz, J. A., Bar\u00f3n, A. E., & Ross, D. (2017). Telemedicine specialty support promotes hepatitis C treatment by primary care providers in the department of veterans affairs. The American Journal of Medicine, 130(4), 432-438.e3. https:\/\/doi.org\/10.1016\/j.amjmed.2016.11.019","journal-title":"The American Journal of Medicine"},{"issue":"3","key":"3770_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ogc.2020.05.003","volume":"47","author":"HL Brown","year":"2020","unstructured":"Brown, H. L., & DeNicola, N. (2020). Telehealth in maternity care. Obstetrics and Gynecology Clinics of North America, 47(3), 497\u2013502. https:\/\/doi.org\/10.1016\/j.ogc.2020.05.003","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"issue":"11","key":"3770_CR11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1055\/s-0041-1728827","volume":"38","author":"ET Bushman","year":"2021","unstructured":"Bushman, E. T., Subramani, L., Sanjanwala, A., Dionne-Odom, J., Franco, R., Owen, J., & Subramaniam, A. (2021). Pragmatic experience with risk-based versus universal hepatitis C screening in pregnancy: Detection of infection and postpartum linkage to care. American Journal of Perinatology, 38(11), 1109\u20131116. https:\/\/doi.org\/10.1055\/s-0041-1728827","journal-title":"American Journal of Perinatology"},{"key":"3770_CR12","volume-title":"Ohio lifts discriminatory barriers to accessing hepatitis C treatment","author":"M Davis","year":"2020","unstructured":"Davis, M. (2020). Ohio lifts discriminatory barriers to accessing hepatitis C treatment. Hepatitis C: State of Medicaid Access."},{"issue":"5","key":"3770_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/M13-1133","volume":"160","author":"MM Denniston","year":"2014","unstructured":"Denniston, M. M., Jiles, R. B., Drobeniuc, J., Klevens, R. M., Ward, J. W., McQuillan, G. M., & Holmberg, S. D. (2014). Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Annals of Internal Medicine, 160(5), 293\u2013300. https:\/\/doi.org\/10.7326\/M13-1133","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"3770_CR14","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/AOG.0000000000004066","volume":"136","author":"OT Hall","year":"2020","unstructured":"Hall, O. T., Hall, O. E., Rood, K. M., McKiever, M. E., Teater, J., & Senay, A. (2020). Pregnancy-associated mortality due to accidental drug overdose and suicide in Ohio, 2009\u20132018. Obstetrics and Gynecology, 136(4), 654\u2013656. https:\/\/doi.org\/10.1097\/AOG.0000000000004066","journal-title":"Obstetrics and Gynecology"},{"key":"3770_CR15","unstructured":"Hepatitis C: State of Medicaid Access. (2022). Hepatitis C: State of Medicaid access report card (p. 2). https:\/\/hepc.wpenginepowered.com\/wp-content\/uploads\/2021\/05\/Ohio-June-2022.pdf"},{"issue":"1","key":"3770_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/liv.14363","volume":"40","author":"C Hollande","year":"2020","unstructured":"Hollande, C., Parlati, L., & Pol, S. (2020). Micro-elimination of hepatitis C virus. Liver International: Official Journal of the International Association for the Study of the Liver, 40(1), 67\u201371. https:\/\/doi.org\/10.1111\/liv.14363","journal-title":"Liver International: Official Journal of the International Association for the Study of the Liver"},{"issue":"5","key":"3770_CR17","doi-asserted-by":"publisher","first-page":"949","DOI":"10.2105\/AJPH.2020.306149","volume":"111","author":"D Holtzman","year":"2021","unstructured":"Holtzman, D., Asher, A. K., & Schillie, S. (2021). The changing epidemiology of hepatitis C virus infection in the United States during the years 2010 to 2018. American Journal of Public Health, 111(5), 949\u2013955. https:\/\/doi.org\/10.2105\/AJPH.2020.306149","journal-title":"American Journal of Public Health"},{"issue":"3","key":"3770_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/wvn.12576","volume":"19","author":"X Liu","year":"2022","unstructured":"Liu, X., Huang, S., Hu, Y., & Wang, G. (2022). The effectiveness of telemedicine interventions on women with postpartum depression: A systematic review and meta-analysis. Worldviews on Evidence-Based Nursing, 19(3), 175\u2013190. https:\/\/doi.org\/10.1111\/wvn.12576","journal-title":"Worldviews on Evidence-Based Nursing"},{"key":"3770_CR19","doi-asserted-by":"publisher","first-page":"103235","DOI":"10.1016\/j.drugpo.2021.103235","volume":"94","author":"D Morales-Arraez","year":"2021","unstructured":"Morales-Arraez, D., Hern\u00e1ndez-Bustabad, A., Medina-Alonso, M. J., Santiago-Guti\u00e9rrez, L. G., Garc\u00eda-Gil, S., Diaz-Flores, F., P\u00e9rez-P\u00e9rez, V., Nazco, J., de Rota, F., Martin, P., Guti\u00e9rrez, F., & Hern\u00e1ndez-Guerra, M. (2021). Telemedicine and decentralized hepatitis C treatment as a strategy to enhance retention in care among people attending drug treatment centres. International Journal of Drug Policy, 94, 103235. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103235","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"3770_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/jvh.13661","volume":"29","author":"LD Nephew","year":"2022","unstructured":"Nephew, L. D., Wang, Y., Mohamed, K., Nichols, D., Rawl, S. M., Orman, E., Desai, A. P., Patidar, K. R., Ghabril, M., Chalasani, N., & Kasting, M. L. (2022). Removal of medicaid restrictions were associated with increased hepatitis C virus treatment rates, but disparities persist. Journal of Viral Hepatitis, 29(5), 366\u2013374. https:\/\/doi.org\/10.1111\/jvh.13661","journal-title":"Journal of Viral Hepatitis"},{"issue":"9","key":"3770_CR21","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s10995-017-2316-x","volume":"21","author":"K Page","year":"2017","unstructured":"Page, K., Leeman, L., Bishop, S., Cano, S., & Bakhireva, L. N. (2017). Hepatitis C cascade of care among pregnant women on opioid agonist pharmacotherapy attending a comprehensive prenatal program. Maternal and Child Health Journal, 21(9), 1778\u20131783. https:\/\/doi.org\/10.1007\/s10995-017-2316-x","journal-title":"Maternal and Child Health Journal"},{"issue":"18","key":"3770_CR22","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2012.3951","volume":"307","author":"SW Patrick","year":"2012","unstructured":"Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2012). Neonatal abstinence syndrome and associated health care expenditures: United States, 2000\u20132009. JAMA, 307(18), 1934\u20131940. https:\/\/doi.org\/10.1001\/jama.2012.3951","journal-title":"JAMA"},{"issue":"3","key":"3770_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.amepre.2020.03.006","volume":"59","author":"AM Rosecrans","year":"2020","unstructured":"Rosecrans, A. M., Cheedalla, A., Rives, S. T., Scotti, L. A., Harris, R. E., Greenbaum, A. H., Irvin, R. R., Ntiri-Reid, B. A., Brown, H. T., Alston, K. E., Smith, J. A., Page, K. R., & Falade-Nwulia, O. O. (2020). Public health clinic-based hepatitis C treatment. American Journal of Preventive Medicine, 59(3), 420\u2013427. https:\/\/doi.org\/10.1016\/j.amepre.2020.03.006","journal-title":"American Journal of Preventive Medicine"},{"issue":"8","key":"3770_CR24","doi-asserted-by":"publisher","first-page":"e186371","DOI":"10.1001\/jamanetworkopen.2018.6371","volume":"1","author":"ES Rosenberg","year":"2018","unstructured":"Rosenberg, E. S., Rosenthal, E. M., Hall, E. W., Barker, L., Hofmeister, M. G., Sullivan, P. S., Dietz, P., Mermin, J., & Ryerson, A. B. (2018). Prevalence of hepatitis C virus infection in US States and the District of Columbia, 2013 to 2016. JAMA Network Open, 1(8), e186371\u2013e186371. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6371","journal-title":"JAMA Network Open"},{"issue":"2","key":"3770_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/AOG.0000000000003644","volume":"135","author":"RM Rossi","year":"2020","unstructured":"Rossi, R. M., Wolfe, C., Brokamp, R., McAllister, J. M., Wexelblatt, S., Warshak, C. R., & Hall, E. S. (2020). Reported prevalence of maternal hepatitis C virus infection in the United States. Obstetrics and Gynecology, 135(2), 387\u2013395. https:\/\/doi.org\/10.1097\/AOG.0000000000003644","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"3770_CR26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","volume":"132","author":"DM Schiff","year":"2018","unstructured":"Schiff, D. M., Nielsen, T., Terplan, M., Hood, M., Bernson, D., Diop, H., Bharel, M., Wilens, T. E., LaRochelle, M., Walley, A. Y., & Land, T. (2018). Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts. Obstetrics and Gynecology, 132(2), 466\u2013474. https:\/\/doi.org\/10.1097\/AOG.0000000000002734","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"3770_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/cid\/ciy899","volume":"69","author":"AH Talal","year":"2019","unstructured":"Talal, A. H., Andrews, P., Mcleod, A., Chen, Y., Sylvester, C., Markatou, M., & Brown, L. S. (2019). Integrated, co-located, telemedicine-based treatment approaches for hepatitis C virus management in opioid use disorder patients on methadone. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 69(2), 323\u2013331. https:\/\/doi.org\/10.1093\/cid\/ciy899","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"key":"3770_CR29","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7132e1","author":"WW Thompson","year":"2022","unstructured":"Thompson, W. W. (2022). Vital signs: Hepatitis C treatment among insured adults\u2014United States, 2019\u20132020. MMWR Morbidity and Mortality Weekly Report. https:\/\/doi.org\/10.15585\/mmwr.mm7132e1","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"24","key":"3770_CR30","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1001\/jama.2012.144878","volume":"308","author":"AJ van der Meer","year":"2012","unstructured":"van der Meer, A. J., Veldt, B. J., Feld, J. J., Wedemeyer, H., Dufour, J.-F., Lammert, F., Duarte-Rojo, A., Heathcote, E. J., Manns, M. P., Kuske, L., Zeuzem, S., Hofmann, W. P., de Knegt, R. J., Hansen, B. E., & Janssen, H. L. A. (2012). Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA, 308(24), 2584\u20132593. https:\/\/doi.org\/10.1001\/jama.2012.144878","journal-title":"JAMA"},{"issue":"2","key":"3770_CR31","first-page":"107","volume":"23","author":"Z Younossi","year":"2017","unstructured":"Younossi, Z., Gordon, S. C., Ahmed, A., Dieterich, D., Saab, S., & Beckerman, R. (2017). Treating Medicaid patients with hepatitis C: Clinical and economic impact. The American Journal of Managed Care, 23(2), 107\u2013112.","journal-title":"The American Journal of Managed Care"},{"issue":"6","key":"3770_CR32","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/ajg.2016.99","volume":"111","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M., Stepanova, M., Henry, L., Nader, F., & Hunt, S. (2016). An in-depth analysis of patient-reported outcomes in patients with chronic hepatitis C treated with different anti-viral regimens. The American Journal of Gastroenterology, 111(6), 808\u2013816. https:\/\/doi.org\/10.1038\/ajg.2016.99","journal-title":"The American Journal of Gastroenterology"},{"issue":"4","key":"3770_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/ADM.0000000000000041","volume":"8","author":"M Zeremski","year":"2014","unstructured":"Zeremski, M., Dimova, R. B., Zavala, R., Kritz, S., Lin, M., Smith, B. D., Zibbell, J. E., & Talal, A. H. (2014). Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance. Journal of Addiction Medicine, 8(4), 249\u2013257. https:\/\/doi.org\/10.1097\/ADM.0000000000000041","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"3770_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12954-021-00486-4","volume":"18","author":"J Ziff","year":"2021","unstructured":"Ziff, J., Vu, T., Dvir, D., Riazi, F., Toribio, W., Oster, S., Sigel, K., & Weiss, J. (2021). Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City. Harm Reduction Journal, 18(1), 38. https:\/\/doi.org\/10.1186\/s12954-021-00486-4","journal-title":"Harm Reduction Journal"}],"container-title":["Maternal and Child Health Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10995-023-03770-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10995-023-03770-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10995-023-03770-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T12:12:21Z","timestamp":1701691941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10995-023-03770-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":31,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["3770"],"URL":"https:\/\/doi.org\/10.1007\/s10995-023-03770-w","relation":{},"ISSN":["1092-7875","1573-6628"],"issn-type":[{"value":"1092-7875","type":"print"},{"value":"1573-6628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"31 August 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This project obtained approval through the Institutional Review Board at our institution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publications"}}]}}